Inspire Medical Systems (INSP) Gains from Investment Securities (2017 - 2026)

Inspire Medical Systems has disclosed Gains from Investment Securities across 9 years of filings, most recently posting $548000.0 for Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $548000.0, up 7.03% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 1272.27% YoY), and the FY2025 annual result was $4.0 million, changed N/A from the prior year.
• Gains from Investment Securities came in at $548000.0 for Q1 2026 at Inspire Medical Systems, down from $2.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $16.9 million in Q4 2023 to a low of -$2.5 million in Q3 2023.
• The 4-year median for Gains from Investment Securities is $548000.0 (2026), against an average of $2.2 million.
• Peak annual rise in Gains from Investment Securities reached 3960.47% in 2023, while the deepest fall reached 2669.79% in 2023.
• Inspire Medical Systems' Gains from Investment Securities stood at $96000.0 in 2022, then jumped by 17512.5% to $16.9 million in 2023, then slumped by 85.34% to $2.5 million in 2025, then slumped by 77.89% to $548000.0 in 2026.
• The last three Gains from Investment Securities figures came in at $548000.0 (Q1 2026), $2.5 million (Q4 2025), and $4.0 million (Q2 2025), per Business Quant data.